Food and Drug Administration

Antiviral Drugs Advisory Committee

August 7, 2002


Clinical Trial Design Issues for Drugs to Treat CHB   htm  ppt

Hepatitis B, Dr. Jay Hoofnagle, MD, NIH    htm  ppt

Clinical Trial Design - Hepatitis B Treatment, Dr. Anna Lok, MD, U. of Michigan  htm   ppt

Pharmaceutic Devepment Issues for Hepatitis B, Dr. Nathaniel Brown, MD, Idenix Pharmaceuticals  htm   ppt

Surrogate Endpoints for Hepatitis B Trials, Dr. Greg Soon, PhD and Dr. Rafia Bhore, PhD, FDA   htm   ppt